AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06646666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 inhibitor
Description: IV 200 mg on D1, Q3W
Study NCT05269264 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessor A (first measurement): measurement methods and questionnaires for the assessment of LLL
Description: pitting test at the level of the foot, leg and midline region; skinfold test at the level of the foot, leg and midline region; skin hardness test at the level of the foot, leg and midline region; measurement with MoistureMeterD at the level of the foot, leg and midline region; measurement with SkinFibroMeter at the level of the foot, leg and midline region; circumference measurements at the level of the leg and midline region; perometry at the level of the leg; water displacement measurement at the level of the foot; measurements with bio-impedance spectroscopy/analysis devices at the level of the lower limbs and a questionnaire regarding skin integrity (ICC compression questionnaire) that should be completed by the therapist and a self-reported disease-specific quality of life questionnaire (Lymph-ICF-LL) that is completed by the patient at the end of this evaluation
Study NCT06165510 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Endocardial Catheter Ablation
Description: Standard percutaneous endocardial catheter ablation of atrial fibrillation
Study NCT05854277 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: educational video
Description: To explain the novel score, a six-minute instructional video was compiled and available to watch, as well as an online tool on the GIEQs website that could be used to grade the image-sets using the score.
Study NCT05412069 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fecobionics
Description: Fecobionics is a novel device to be inserted through the anal canal into rectum for studying defecation. Anorectal manometry, balloon expulsion test, and anal ultrasonography will be used as reference.
Study NCT05265169 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microwave ablation
Description: Microwave ablation of colorectal liver metastases (CLM)
Study NCT05269264 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessor B: measurement methods and questionnaires for the assessment of LLL
Description: pitting test at the level of the foot, leg and midline region; skinfold test at the level of the foot, leg and midline region; skin hardness test at the level of the foot, leg and midline region; measurement with MoistureMeterD at the level of the foot, leg and midline region; measurement with SkinFibroMeter at the level of the foot, leg and midline region; circumference measurements at the level of the leg and midline region; perometry at the level of the leg; water displacement measurement at the level of the foot; measurements with bio-impedance spectroscopy/analysis devices at the level of the lower limbs and a questionnaire regarding skin integrity (ICC compression questionnaire) that should be completed by the therapist
Study NCT05269264 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessor A (second measurement: measurement methods and questionnaires for the assessment of LLL
Description: pitting test at the level of the foot, leg and midline region; skinfold test at the level of the foot, leg and midline region; skin hardness test at the level of the foot, leg and midline region; measurement with MoistureMeterD at the level of the foot, leg and midline region; measurement with SkinFibroMeter at the level of the foot, leg and midline region; circumference measurements at the level of the leg and midline region; perometry at the level of the leg; water displacement measurement at the level of the foot; measurements with bio-impedance spectroscopy/analysis devices at the level of the lower limbs and a questionnaire regarding skin integrity (ICC compression questionnaire) that should be completed by the therapist
Study NCT05269264 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessor A (2 weeks later): measurement methods and questionnaires for the assessment of LLL
Description: pitting test at the level of the foot, leg and midline region; skinfold test at the level of the foot, leg and midline region; skin hardness test at the level of the foot, leg and midline region; measurement with MoistureMeterD at the level of the foot, leg and midline region; measurement with SkinFibroMeter at the level of the foot, leg and midline region; circumference measurements at the level of the leg and midline region; perometry at the level of the leg; water displacement measurement at the level of the foot; measurements with bio-impedance spectroscopy/analysis devices at the level of the lower limbs and a questionnaire regarding skin integrity (ICC compression questionnaire) that should be completed by the therapist and a self-reported disease-specific quality of life questionnaire (Lymph-ICF-LL) that is completed by the patient at the end of this evaluation
Study NCT05607784 — intervention group
Intervention type: BEHAVIORAL
Intervention: Formative Research- Content Translation
Description: This formative research includes brainstorming translation of content and reviewing wireframe prototypes generated from this process. It also includes attending to cultural, developmental, and gender considerations.~The design development cycles will begin with advisory focus group feedback about how the existing activities convey the content (i.e., what and how they are learning). They will advise on activity design for the remaining content (sexual health and content connecting this with ER) to ensure these are engaging, appropriate, and informative. They will also provide perspectives about design, structure, navigability, and approach
Study NCT05607784 — intervention group
Intervention type: BEHAVIORAL
Intervention: Formative Research- Content Feedback and Acceptability
Description: This formative research includes providing feedback on the proposed content and ensure contextual acceptability in schools.~The design development cycles will begin with advisory focus group feedback about how the existing activities convey the content (i.e., what and how they are learning). They will advise on activity design for the remaining content (sexual health and content connecting this with ER) to ensure these are engaging, appropriate, and informative. They will also provide perspectives about design, structure, navigability, and approach
Study NCT04429945 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Virtual Reality Headset with Virtual Reality Applications
Study NCT04671862 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: Parameters: combined 633nm and 870 nm @1000mW~* 1 Treatment 4J continuous prior to RT. (Within 14 days of RT start)~* 3 treatments weekly during RT (6 J at 12 Hz, 80% duty cycle)
Study NCT05357781 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory test
Description: Frequency of fatigue (defined as Fatigue Scala for Motor and Cognitive Function (FSMC) total ≥ 43 points) in MS patients with IgG-deficiency
Study NCT05392634 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meropenem 1000 mg
Description: Group B: prolonged antibiotic prophylaxis >72 hours (5 days) from the moment of the skin incision in accordance with the selected clinic drug + correction of the appointment based on clinical events after 5 days.
Study NCT05392634 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin+clavulanic acid 1200 mg or Cefuroksim 1500mg
Description: Group A: antibiotic prophylaxis within 24 hours from the moment of skin incision according to local clinical practice;
Study NCT05198232 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Zumba High Tempo
Description: The Zumba high tempo group will complete a 10-week (2x a week; 60 minutes per session) virtual adapted aerobic dance intervention (adapted Zumba®). Each session will consist of: a warm-up (3-5 minutes), 5-6 songs with instruction (40 minutes), and a cool down (5 minutes) for a total of about 60 minutes including rest/water breaks and time to transition. The only difference between the two adapted Zumba® programs will be the speed at which the songs will be played and the number of times through each song. The songs for the high-tempo group will be played at full speed; the songs in the high-tempo group will be repeated to ensure an equal amount of time moving for both groups. All sessions will be video recorded and examined for fidelity. This group will complete pre-test, post-test, and a 4-week follow-up.
Study NCT05198232 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Zumba Low Tempo
Description: The Zumba low tempo group will complete a 10-week (2x a week; 60 minutes per session) virtual adapted aerobic dance intervention (adapted Zumba®). Each session will consist of: a warm-up (3-5 minutes), 5-6 songs with instruction (40 minutes), and a cool down (5 minutes) for a total of about 60 minutes including rest/water breaks and time to transition. The only difference between the two adapted Zumba® programs will be the speed at which the songs will be played and the number of times through each song. The songs for the low-tempo group will be set to three-fourths speed. All sessions will be video recorded and examined for fidelity. This group will complete pre-test, post-test, and a 4-week follow-up.
Study NCT06146465 — intervention group
Intervention type: OTHER
Intervention: speciality
Description: Not
Study NCT05772767 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Biological sample collection
Description: Collection of tumor tissue and blood for stem cell culture and organoids generation.
Study NCT05772767 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Dissecting ciliogenesis players
Description: Assessment of cilium-related transcriptome in glioblastoma stem cells. Modulation of cilium-related genes and administration of cilium-targeted drugs to glioblastoma stem cells in vitro and ex vivo in glioblastoma brain organoids.
Study NCT05772767 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Validating ciliogenesis players
Description: Cilium-related signature will be studied in tumor tissue to evaluate its prognostic role.
Study NCT05441930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin Ocular Implant
Description: Levofloxacin Ocular Implant an implant that delivers a bolus dose of levofloxacin and a constant daily dose for a further 5-7 days.
Study NCT05441930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Commercially available topical medications as per LEVO-CS102 Surgical Therapy Procedure.
Study NCT05388448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sanfetrinem Cilexetil
Description: Sanfetrinem cilexetil powder, weighed for dose and administered as a suspension in water.~Amx/CA 250/125 mg tablets Rifampicin 150 mg, 300 mg and 600 mg tablets or capsules
Study NCT05388448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid
Description: Amx/CA will be administered orally as Amx/CA 250/125 mg, 1 tablet twice daily for 14 days alongside with sanfetrinem cilexetil.
Study NCT05388448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin
Description: Rifampicin will be administered at a dose of 35 mg/kg once daily for 14 days with or without sanfetrinem cilexetil.
Study NCT04992338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile app
Description: The CarpeDiem application is a mobile application, designed in collaboration with the Health and Nutrition Technology Unit (UTNS, Eurecat) and the translational research group on respiratory medicine of the Institut de Recerca Biomèdica de Lleida. The application is available for devices with Android as the operative system and its advanced interface allows the user to monitor their physical activity, sleep and diet and motivate them to meet personalized goals through gamification. To do this, the user must answer the questionnaires that they will find on the main page of the application with a predetermined frequency, as well as perform missions that will help them acquire healthier habits. In addition, the user will receive motivational messages and recommendations through notifications that will help and guide them to achieve their missions and achieve their goals, and as a result of changing habits.
Study NCT04477317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4% Articaine Hydrochloride with 1:100,000 Adrenaline
Description: new Egyptian articane anesthetic solution.
Study NCT04477317 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2% Mepivacaine Hydrochloride with 1:20,000 Levonordefrin
Description: Mepecaine-L is the brand name of the Egyptian 2% Mepivacaine. It is the most commonly used anesthetic solution in Egypt due to its availability and its lower cost.
Study NCT05741775 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic training
Description: The warm-up exercise will include light aerobic activity and some dynamic stretching movements. Similarly, the cool down exercises will include buttock stretch, hamstring stretch, inner thigh stretch, calf stretch and thigh stretch. Each stretch to be performed for 5 repetitions with a hold time of 15 seconds for each. An elastic band secured around the head will be used to apply local pressure over the area. Kettler Computeranleitung Advanced display will be used to train static cycling. ProAction BH Treadmill G6700 instrument will be used for aerobic training.
Study NCT05741775 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofeedback Training
Description: Neurotrac myoplus 4 pro instrument will be used for EMG biofeedback training.
Study NCT05474573 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Combined ultrasound and fluorescence-guided brain tumor resection
Description: Surgeon intraoperatively assesses extent of tumor resection observing it's fluorescence in microscope and performing sonography
Study NCT05474573 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fluorescence-guided brain tumor resection
Description: Surgeon intraoperatively assesses extent of tumor resection observing it's fluorescence in microscope
Study NCT06270576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lipopolysaccharides
Description: LPS aka endotoxin is a component of bacterial cell walls and is ubiquitous in the environment. It is found in pet dander, house dust and environmental dusts and has been heavily studied in asthma.
Study NCT04816162 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ketofol
Description: prepared in a ratio of (1:4) respectively), where 1ml of ketamine will be added to 20 ml of propofol in a syringe pump
Study NCT04816162 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexmedetomidine
Description: 2 ml (200 µg) of dexmedetomidine added to 0.9% normal saline in a syringe pump
Study NCT04816162 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: normal saline 0.9% in a syringe pump
Study NCT04959006 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Antioxidant supplement
Description: Short term (16d) supplementation of either the antioxidant supplement (Oliphenolia) or placebo. Participants required to consume 2x25ml drinks, one mid-morning, one mid-afternoon between meals.
Study NCT06127342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise
Description: Participants will wear a heartrate monitor and cycle on a stationary bike at a slow speed for 5 minutes, then slowly cycle on a stationary bike for 30 minutes, then cycle on the stationary bike at a slow speed for 5 minutes.
Study NCT06127342 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low Intensity Exercise
Description: Participants will wear a heartrate monitor and cycle on a stationary bike at a slow speed for 40 minutes.
Study NCT06574451 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VR-assisted postoperative analgesia
Description: Patients will receive postoperative analgesic adjunctive therapy software to assist in pain control, with one postoperative analgesic adjunctive therapy software intervention at 24 hours and 48 hours after surgery, and pain evaluation within 30 minutes.
Study NCT06575322 — intervention group
Intervention type: DRUG
Intervention: Carboplatin（ neoadjuvant）
Description: Carboplatin (IV), AUC=5，administered by intravenous (IV) infusion on Day 1 of each 21-day cycle
Study NCT06575322 — intervention group
Intervention type: DRUG
Intervention: Paclitaxel （neoadjuvant）
Description: Nab-paclitaxel 260mg/m2 administered by intravenous (IV) infusion on Day 1 of each 21-day cycle
Study NCT06575322 — intervention group
Intervention type: DRUG
Intervention: Anti-PD-1 Drugs
Description: Anti-PD-1 Drugs 200 mg administered by intravenous (IV) infusion on Day 1 of each 21-day cycle
Study NCT04959006 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06575322 — intervention group
Intervention type: PROCEDURE
Intervention: Surgical resection
Description: Standard of care
Study NCT05112081 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: The group will receive a solution of 100 units BTX with 10 ml sterile saline close to the superficial inguinal ring.
Study NCT05112081 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sterile saline
Description: The group will receive a solution of 10 ml sterile saline close to the superficial inguinal ring.
Study NCT05002634 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: undenatured collagen type II (UCII) supplement
Description: The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months.
Study NCT05439096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Exercise
Description: Among Functional Exercises, cobra position is most effective in reducing pelvic pain while others are cat and fish position.Kegel exercises along with other strengthening activities for pelvic floor muscles have been accounted for in writing to favorably affect primary dysmenorrheal.
Study NCT05439096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Frequency Transcutaneous Electrical Nerve Stimulation
Description: Transcutaneous electrical nerve stimulation, best treat primary dysmenorrhea. Transcutaneous Electrical Nerve Stimulation is proposed as an incredible spasm decrease, lessening torment, decline of analgesics and improving personal satisfaction in primary dysmenorrhea patients.
Study NCT05098652 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CuRB-IT
Description: 9 1-hour coaching sessions delivered over a videoconferencing platform (Zoom); 6 delivered weekly, 3 delivered biweekly
Study NCT05098652 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CuRB-IT
Description: 9 1-hour coaching sessions delivered over a videoconferencing platform (Zoom); 6 delivered weekly, 3 delivered biweekly
Study NCT05005507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-73763989
Description: JNJ-73763989 will be administered subcutaneously once every 4 weeks.
Study NCT05005507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PegIFN-alpha-2a
Description: PegIFN-alpha-2a will be administered subcutaneously once weekly.
Study NCT05005507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil
Description: Tenofovir disoproxil film-coated tablet will be administered orally once daily.
Study NCT05005507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAF
Description: TAF film-coated tablet will be administered orally once daily.
Study NCT05005507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ETV
Description: ETV film-coated tablet will be administered orally once daily.
Study NCT04811872 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intact umbilical cord milking (I-UCM)
Description: Umblical cord milking will be performed by holding the newborn at or ∼20 cm below the level of the placenta. The cord will be pinched between 2 fingers as close to the placenta as possible and milked toward the infant over a 2-second duration. The cord will then be released and allowed to refill with blood for a brief 1- to 2-second pause between each milking motion. This will be repeated for 2-4 times. After completion, the cord will be clamped, and the neonate will be handed to the resuscitation team.
Study NCT04811872 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cut-umbilical cord milking(C-UCM)
Description: This technique involves clamping and cutting a long segment of the umbilical cord immediately at birth and passing the baby and the long cord to the pediatric provider, called C-UCM untwists the cord and milks the entire contents into the baby. Milking the cord 2-3 times before clamping may produce a similar placental transfusion as C-UCM.
Study NCT04811872 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Delayed Cord Clamping (DCC)
Description: Infants placed on the maternal abdomen or at the introitus below the level of placenta and waiting at least 30- to 60 seconds before clamping the cord.
Study NCT05584956 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: L_carnitine
Description: l-carnitine stabilizes red blood cell membranes and thus improves the anemic state\[
Study NCT05584956 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sildenafil
Description: selective and potent inhibitor of cGMP-specific phosphodiesterase 5 (PDE5), which promotes smooth muscle relaxation in lung vasculature, has been used successfully in the treatment of primary and secondary PH.